Medicare Enrolled

Dr. Brendan Bauer, MD

Neurology · Sheffield Village, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
5319 HOAG DR STE 210, Sheffield Village, OH 44035
4194832403
In practice since 2006 (20 years)
NPI: 1245202043 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bauer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bauer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bauer

Dr. Brendan Bauer is a neurology specialist in Sheffield Village, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bauer performed 2,184 Medicare services across 1,199 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bauer received a total of $580,843 from 81 pharmaceutical and/or device companies across 1713 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bauer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 11% volume in OH $580,843 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,184
Medicare services
Top 11% in OH for neurology
1,199
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
672 $88 $240
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
366 $0 $4
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
178 $66 $160
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
162 $71 $272
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
85 $116 $310
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
81 $189 $649
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
76 $81 $313
Brachial plexus injection with anesthetic and/or steroid
An injection of an anesthetic agent and/or steroid into the brachial plexus nerve bundle in the arm.
57 $122 $376
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
56 $11 $65
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
42 $53 $338
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
42 $62 $104
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
41 $43 $320
Electrocardiogram, 1-3 leads with physician review
A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician.
35 $10 $35
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
35 $286 $895
Visual evoked potential test
A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli.
35 $50 $247
Digital analysis of brain wave activity (EEG)
This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision.
35 $209 $690
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
35 $102 $330
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
35 $25 $90
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
35 $104 $330
Auditory brainstem response test
A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional.
34 $65 $210
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
29 $99 $198
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $87 $205
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$580,843
Total received (2018-2024)
Avg $82,978/year across 7 years
Top 2% in OH for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
1,713
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$567,907 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,935 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65,721
2023
$44,313
2022
$97,333
2021
$69,233
2020
$59,740
2019
$123,666
2018
$120,837

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$44,804
Mallinckrodt Hospital Products Inc.
$12,121
ABBVIE INC.
$5,043
TG Therapeutics, Inc.
$444
PFIZER INC.
$266
CSL Behring
$236
ARGENX US, INC.
$225
UCB, Inc.
$219
Genentech USA, Inc.
$219
ACADIA Pharmaceuticals Inc
$199
Avadel CNS Pharmaceuticals, LLC
$181
Nevro Corp.
$152
Grifols USA, LLC
$140
Celgene Corporation
$140
Alexion Pharmaceuticals, Inc.
$139
Teva Pharmaceuticals USA, Inc.
$116
Biogen, Inc.
$98
Lilly USA, LLC
$96
SK Life Science, Inc.
$92
Otsuka America Pharmaceutical, Inc.
$85
Eisai Inc.
$85
Lundbeck LLC
$78
Neurelis, Inc.
$65
Amneal Pharmaceuticals LLC
$59
Novartis Pharmaceuticals Corporation
$58
MITSUBISHI TANABE PHARMA AMERICA, INC.
$57
JAZZ PHARMACEUTICALS INC.
$57
Axsome Therapeutics, Inc.
$55
Neurocrine Biosciences, Inc.
$52
Supernus Pharmaceuticals, Inc.
$43
Azurity Pharmaceuticals, Inc.
$35
Takeda Pharmaceuticals U.S.A., Inc.
$24
Merz Pharmaceuticals, LLC
$22
LivaNova USA, Inc.
$14
Top 3 companies account for 94.3% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$177,419
Biogen, Inc.
$161,982
GENZYME CORPORATION
$123,402
ABBVIE INC.
$20,205
AbbVie Inc.
$18,854
Biohaven Pharmaceutical Holding Company Ltd.
$17,205
Biohaven Pharmaceuticals, Inc.
$14,051
Allergan, Inc.
$13,714
Mallinckrodt Hospital Products Inc.
$12,162
Amgen Inc.
$6,369
Lundbeck LLC
$2,241
BANNER LIFE SCIENCES, LLC
$958
Teva Pharmaceuticals USA, Inc.
$832
Genentech USA, Inc.
$830
UCB, Inc.
$698
PFIZER INC.
$663
Supernus Pharmaceuticals, Inc.
$621
ACADIA Pharmaceuticals Inc
$556
Lilly USA, LLC
$458
ARGENX US, INC.
$450
CSL Behring
$449
TG Therapeutics, Inc.
$444
Novartis Pharmaceuticals Corporation
$435
Eisai Inc.
$415
Celgene Corporation
$408
Alexion Pharmaceuticals, Inc.
$392
JAZZ PHARMACEUTICALS INC.
$315
EISAI INC.
$302
Otsuka America Pharmaceutical, Inc.
$268
SK Life Science, Inc.
$243
TG THERAPEUTICS, INC.
$223
Neurocrine Biosciences, Inc.
$219
Grifols USA, LLC
$208
Adamas Pharmaceuticals, Inc.
$200
Janssen Pharmaceuticals, Inc
$191
Avadel CNS Pharmaceuticals, LLC
$181
Mallinckrodt LLC
$176
Horizon Therapeutics plc
$174
US WorldMeds, LLC
$173
Nevro Corp.
$152
Acorda Therapeutics, Inc
$142
Neurelis, Inc.
$119
Axsome Therapeutics, Inc.
$106
SANOFI-AVENTIS U.S. LLC
$99
Bayer HealthCare Pharmaceuticals Inc.
$87
Kyowa Kirin, Inc.
$81
Amneal Pharmaceuticals LLC
$78
Greenwich Biosciences, Inc.
$68
MITSUBISHI TANABE PHARMA AMERICA, INC.
$57
Upsher-Smith Laboratories LLC
$57
Azurity Pharmaceuticals, Inc.
$51
LivaNova USA, Inc.
$50
Shire North American Group Inc
$38
Abbott Laboratories
$32
Egalet US Inc
$28
Collegium Pharmaceutical, Inc.
$27
Medtronic USA, Inc.
$27
Assertio Therapeutics, Inc.
$26
BioDelivery Sciences International, Inc.
$25
Banner Life Sciences, LLC
$25
Almatica Pharma LLC
$24
Takeda Pharmaceuticals U.S.A., Inc.
$24
Merz North America, Inc.
$23
Exeltis, USA Inc.
$22
Merz Pharmaceuticals, LLC
$22
Allergan Inc.
$22
AbbVie, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$21
Purdue Pharma L.P.
$20
Gilead Sciences, Inc.
$20
ANI Pharmaceuticals, Inc.
$18
Daiichi Sankyo Inc.
$18
Neos Therapeutics, LP
$17
Mitsubishi Tanabe Pharma America, Inc.
$16
Avanir Pharmaceuticals, Inc.
$15
GE Healthcare
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Impax Laboratories, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Arbor Pharmaceuticals, Inc.
$13
CATALYST PHARMACEUTICALS, INC.
$12
Top 3 companies account for 79.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · AUBAGIO · AUSTEDO · AVONEX · Aduhelm · Adzenys XR-ODT · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · BUNAVAIL 2.1 mg 30-count box · Betaseron · Briviact · COMIRNATY · DISEASE STATE · DUOPA · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Evrysdi · FIRDAPSE · Fintepla · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · HORIZANT · HYQVIA · HYSINGLA ER · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · LEMTRADA · LUMRYZ · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MYDAYIS · MYSTIM · Mavenclad · Morphabond ER · NAMZARIC · NAPRELAN · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · ONFI · OXTELLAR XR · Ocrevus · Ongentys · PURIFIED CORTROPHIN GEL · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qelbree · RADICAVA · RAYOS · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · Senza · Soliris · Sunosi · TECFIDERA · TOPIRAMATE Extended Release Capsules · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Veklury · XCOPRI · XEOMIN · XTAMPZAER · XYWAV · Xembify · Xeomin · ZEPOSIA · ZINBRYTA · Zembrace SymTouch Sumatriptan Injection
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for neurology in OH.

Looking for a neurology specialist in Sheffield Village?
Compare neurologists in the Sheffield Village area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
34
Per 100K population
10.8
County median income
$70,693
Nearest hospital
UNIVERSITY HOSPITALS - ELYRIA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bauer is a clinical cardiology specialist, with above-average Medicare volume (top 11% in OH), with speaking/promotional industry engagement in the top 2% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bauer experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bauer performed 672 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bauer receive payments from pharmaceutical companies?
Yes. Dr. Bauer received a total of $580,843 from 81 companies across 1,713 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bauer's costs compare to other neurologists in Sheffield Village?
Dr. Bauer's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bauer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →